文献
J-GLOBAL ID:201702222430373797
整理番号:17A0071156
進行肺非小細胞癌患者におけるパクリタキセルとカルボプラチンと併用した経口サブタイプ選択的ヒストンデアセチラーゼ阻害剤である、キダマイド,の第I相試験【Powered by NICT】
A phase I trial of an oral subtype-selective histone deacetylase inhibitor,chidamide,in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer
著者 (7件):
Hu Xingsheng
(Department of Medical Oncology,National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College)
,
Wang Lin
(Department of Medical Oncology,National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College)
,
Lin Lin
(Department of Medical Oncology,National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College)
,
Han Xiaohong
(Department of Medical Oncology,National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College)
,
Dou Guifang
(Laboratory of Drug Metabolism and Pharmacokinetics, Beijing Institute of Transfusion Medicine)
,
Meng Zhiyun
(Laboratory of Drug Metabolism and Pharmacokinetics, Beijing Institute of Transfusion Medicine)
,
Shi Yuankai
(Department of Medical Oncology,National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College)
資料名:
Zhongguo Aizheng Yanjiu(Yingwenban)
(Zhongguo Aizheng Yanjiu(Yingwenban))
巻:
28
号:
4
ページ:
444-451
発行年:
2016年
JST資料番号:
C2634A
ISSN:
1000-9604
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
中国 (CHN)
言語:
英語 (EN)